Success Metrics

Clinical Success Rate

100.0%

Based on 8 completed trials

Completion Rate

100%(8/8)

Active Trials

0(0%)

Results Posted

25%(2 trials)

Phase Distribution

Ph phase_4

33%

Ph not_applicable

33%

Ph phase_1

11%

Ph phase_2

11%

Ph phase_3

11%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution9 total trials

Phase 1Safety & dosage

1(11.1%)

Phase 2Efficacy & side effects

1(11.1%)

Phase 3Large-scale testing

1(11.1%)

Phase 4Post-market surveillance

3(33.3%)

N/ANon-phased studies

3(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(8)

Terminated(1)

Detailed Status

Completed8

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (11.1%)

Phase 21 (11.1%)

Phase 31 (11.1%)

Phase 43 (33.3%)

N/A3 (33.3%)

Trials by Status

completed889%

withdrawn111%

Recent Activity

0 active trials

Showing 5 of 9

completednot_applicable

Dexmedetomidine Improves Recovery After Cranial Aneurysm Surgery

NCT03355534

completedphase_3

Minimal Effective Concentration (EC90) of Ropivacaine

NCT03688269

completednot_applicable

Characterization of Metabolic and Brain Effects of Rising Glucagon During an Oral Glucose Challenge

NCT03061227

completedphase_4

Effect of Topical and Intravenous Tranexamic Acid (TXA) on Thrombogenic Markers in Patients Undergoing Knee Replacement

NCT02540226

completedphase_4

Interscalene Block With Low-dose IV vs. Perineural Dexamethasone for Shoulder Arthroscopy

NCT02506660

View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials

NCT03355534Not Applicable

Dexmedetomidine Improves Recovery After Cranial Aneurysm Surgery

Completed

NCT03688269Phase 3

Minimal Effective Concentration (EC90) of Ropivacaine

Completed

NCT03061227Not Applicable

Characterization of Metabolic and Brain Effects of Rising Glucagon During an Oral Glucose Challenge

Completed

NCT02540226Phase 4

Effect of Topical and Intravenous Tranexamic Acid (TXA) on Thrombogenic Markers in Patients Undergoing Knee Replacement

Completed

NCT02506660Phase 4

Interscalene Block With Low-dose IV vs. Perineural Dexamethasone for Shoulder Arthroscopy

Completed

NCT02731664Phase 1

GLP-1 Inhibits Prandial Antro-duodeno-jejunal Motility in Humans

Completed

NCT02084771Phase 4

Oral Salt and Water to Prevent Contrast Nephropathy

Withdrawn

NCT01539798Not Applicable

Body Composition and Serum Biochemistry After Intravenous Infusion or Oral Intake of Saline in Healthy Volunteers

Completed

NCT00227448Phase 2

Induced Hypertension for Acute Ischemic Stroke

Completed

All 9 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 9